FDA Adverse Event Death Summary report: N

RESOLUTE INTEGRITY RX

MDR report key: 4890916 · Received July 6, 2015

Report

Report Number
9612164-2015-01206
Event Type
Death
Date Received
July 6, 2015
Date of Event
December 7, 2013
Report Date
October 6, 2015
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P110013
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT HAD A HISTORY OF HYPERTENSION, HYPERLIPIDEMIA, DIABETES AND PREVIOUS PCI. INDEX PROCEDURE WAS PROMPTED BY STABLE ANGINA. DURING THE INDEX PROCEDURE THE 3 RSINT STENTS WERE IMPLANTED IN THE FOLLOWING VESSELS, 2 IN THE CX AND THE 3RD IN THE 2ND OM. DURING A STAGED PROCEDURE APPROX. ONE MONTH LATER ANOTHER 4 RESOLUTE INTEGRITY DRUG-ELUTING STENTS WERE IMPLANTED IN THE RCA. IT WAS ASSESSED THAT THE STROKE AND CARDIAC DEATH WERE NOT RELATED TO THE STUDY STENTS.

Additional Manufacturer Narrative · 1

CEC HAS ADJUDICATED THE PREVIOUSLY REPORTED DEATH WAS NOT RELATED TO THE STUDY DEVICE.

Additional Manufacturer Narrative · 1

EVALUATION CODES, RESULTS: INHERENT RISK OF PROCEDURE ¿ (CVA/STROKE,DEATH) EVALUATION CODES, CONCLUSIONS: INHERENT RISK OF PROCEDURE ¿ (CVA/STROKE,DEATH) (B)(4).

Description of Event or Problem · 1

THREE RESOLUTE INTEGRITY DRUG-ELUTING STENTS WERE IMPLANTED; ONE IN THE 2ND DIAGONAL, LCX AND 2ND OM DURING THE INDEX PROCEDURE . APPROXIMATELY 4 DAYS POST INDEX PROCEDURE PATIENT SUFFERED CEREBROVASCULAR DISORDER PATIENT WAS HOSPITALISED FOR TREATMENT. APPROXIMATELY 3 MONTHS POST INDEX PROCEDURE PATIENT EXPIRED. CAUSE OF DEATH WAS CARDIAC DEATH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
436215 RESOLUTE INTEGRITY RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 00076 YR Death| H